Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fink, J. K.
Right arrow Articles by Barton, N. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fink, J. K.
Right arrow Articles by Barton, N. W.
NEUROLOGY 1989;39:1393
© 1989 American Academy of Neurology

Tetrahydrobiopterin administration in biopterin-deflcient progressive dystonia with diurnal variation

J. K. Fink, MD, P. Ravin, MD, C. E. Argoff, MD, R. A. Levine, PhD, R. O. Brady, MD, M. Hallett, MD and N. W. Barton, MD, PhD

Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD (Drs. Fink, Argoff, Brady, and Barton)
Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, Bethesda, MD (Dr. Hallett)
Department of Neurology, University of Massachusetts Medical Center, Worcester, MA (Dr. Ravin)
Department of Psychiatry, Wayne State University, Detroit, MI. (Dr. Levine)

We administered tetrahydrobiopterin (BH4) to 4 patients with progressive dystonia with diurnal variation (PDDV). One patient improved clinically. Deficient CSF concentrations of HVA and 5-HIAA were unchanged despite marked elevation of CSF biopterin concentration. Variable effectiveness of BH4 in PDDV may reflect reduced number or function of biopterin-metabolizing neurons or variable entry of BH4 into these neurons.

Address correspondence and reprint requests to Dr. Fink, Building 10, Room 3D03, NINDS, NIH, Bethesda, MD 20892.

Received February 6, 1989. Accepted for publication in final form April 26, 1989.




This article has been cited by other articles:


Home page
NeurologyHome page
Y. Furukawa, T. G. Nygaard, M. Gutlich, A. H. Rajput, C. Pifl, L. DiStefano, L. J. Chang, K. Price, M. Shimadzu, O. Hornykiewicz, et al.
Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia
Neurology, September 1, 1999; 53(5): 1032 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. K. Fink, P. D. Ravin, M. Filling-Katz, C. E. Argoff, and M. Hallett
Clinical and Genetic Analysis of Progressive Dystonia With Diurnal Variation
Arch Neurol, September 1, 1991; 48(9): 908 - 911.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.